Either switch to oral therapy: 500 mg of Ciprofloxacin (oral)

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis

Drug Information

Target Indication

Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis

Clinical Trial

Last updated: 3/11/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

PFE

PFIZER

Related Pipeline

Tick-borne Encephalitis

Glioblastoma

Pneumococcal Infections

Pneumococcal Disease

Multiple Myeloma